Combination Acid‑Suppression Strategy for Severe Heartburn Associated with GLP‑1 Receptor Agonist Therapy

PPI Dose Escalation

In patients with refractory acid‑related symptoms, the American Gastroenterological Association (AGA) clinical practice update (2022) recommends increasing omeprazole from 20 mg once daily to 20 mg twice daily when a single daily dose is insufficient 1.
Full‑dose omeprazole (20 mg once daily) is the first‑line therapy for epigastric pain and ulcer‑like dyspepsia; escalation to twice‑daily dosing is appropriate if symptoms persist, according to Gut (2002) 2.

The AGA advises adding a nighttime H2‑receptor antagonist for nocturnal heartburn symptoms; famotidine 20 mg taken at bedtime provides additional acid suppression 1.
Famotidine 20 mg daily yields approximately six hours of acid suppression, supporting its role for breakthrough symptoms (Praxis Medical Insights, 2026) 4.

Continuous daily famotidine develops tachyphylaxis within 4–6 weeks, markedly reducing its long‑term efficacy (Praxis Medical Insights, 2026) 4.
Consequently, famotidine should be used intermittently for breakthrough relief, and clinicians should reassess its effectiveness after 4–6 weeks (Praxis Medical Insights, 2026) 4.
If tachyphylaxis occurs, switching to on‑demand famotidine or alternative strategies is recommended (Gut, 2002) 3.

GLP‑1 receptor agonists frequently cause transient gastrointestinal adverse effects, including heartburn, especially during dose escalation (Metabolism: Clinical and Experimental, 2024) 5.
Slow up‑titration of the GLP‑1 RA mitigates these gastrointestinal symptoms (Metabolism: Clinical and Experimental, 2024) 5.

The AGA emphasizes that proton‑pump inhibitors are safe for GERD treatment, with a favorable adverse‑event profile at doses up to 40 mg daily (Clinical Gastroenterology and Hepatology, 2022) 1.
Famotidine is generally safe and does not interfere with antiplatelet agents such as clopidogrel (Praxis Medical Insights, 2026) 4.

Step 1: Increase omeprazole to 20 mg twice daily, taken 30–60 minutes before breakfast and dinner (AGA recommendation) 1.
Step 2: Add famotidine 20 mg at bedtime for nocturnal or breakthrough heartburn (AGA and Praxis guidance) [1][4].
Step 3: Continue the combination for 4–8 weeks while monitoring symptom response (AGA) 1.
Step 4: Reassess at 4–6 weeks; if symptoms have resolved, taper to the lowest effective PPI dose and discontinue famotidine or shift to on‑demand use because of tachyphylaxis (AGA and Praxis) [1][4].

If heartburn persists despite the above regimen, perform upper endoscopy to evaluate for erosive esophagitis, hiatal hernia, or Barrett’s esophagus (AGA) 1.
Consider 24‑hour pH‑impedance monitoring off PPI therapy to objectively confirm gastro‑esophageal reflux (AGA) 1.
Evaluate the possibility of a functional esophageal disorder when acid‑related pathology is not identified (AGA) 1.